Acknowledgments
IASLC acknowledges the generous funding and support provided by Pfizer Oncology for this ALK Atlas project. The co-editors and all contributors also acknowledge the editorial assistance of Lori Alexander, MTPW, ELS, and support of Deborah A. Whippen, Editorial Rx, Inc., and Rania Gaspo, PhD, Pfizer Oncology, during the preparation of this publication.